NCT05193396View on ClinicalTrials.gov

Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Adrenal InsufficiencyPolymyalgia Rheumatica (PMR)Giant Cell Arteritis (GCA)
Interventions
DRUG

Hydrocortisone

Patients are randomized to oral hydrocortisone (10 mg twice daily) or placebo for 16 weeks.

DRUG

Placebo

Patients are randomized to oral hydrocortisone (10 mg twice daily) or placebo for 16 weeks.

Trial Locations (3)

5230

RECRUITING

Department of Endocrinology, Odense University Hospital, Odense

Unknown

RECRUITING

Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus

RECRUITING

Department of Nephrology and Endocrinology, Rigshospitalet, Copenhagen

All Listed Sponsors
collaborator

Aarhus University Hospital

OTHER

collaborator

Copenhagen University Hospital, Denmark

OTHER

lead

Marianne Andersen

OTHER